CLI Subgroup Analysis From the US SAFE-DCB Registry: Final 3-year Follow-up Results
In this video recorded at AMP 2024, interventional cardiologist Thomas Davis, MD, from Eastlake Cardiovascular in St. Clair Shores, Michigan, discusses his presentation on the SAFE-DCB registry, a prospective, multicenter, single-arm, real-world US registry assessing the clinical use, safety, and outcomes of the Lutonix 035 drug-coated balloon (BD) in the superficial femoral and popliteal arteries.
About Us
Vascular Disease Management™ (VDM), the official media partner of the International Symposium on Endovascular Therapy (ISET) and the Amputation Prevention Symposium (AMP), is a peer-reviewed journal that educates readers on the latest advancements in endovascular treatment strategies.
Learn more about ISET and AMP and register for the events here:




